Human-derived Treg and MSC combination therapy may augment immunosuppressive potency in vitro, but did not improve blood brain barrier integrity in an experimental rat traumatic brain injury model

Caplan, H. W., Prabhakara, K. S., Toledano Furman, N. E., Zorofchian, S., Martin, C., Xue, H., Olson, S. D. and Cox, C. S.  Human-derived Treg and MSC combination therapy may augment immunosuppressive potency in vitro, but did not improve blood brain barrier integrity in an experimental rat traumatic brain injury model.  PLOS ONE. 2021; 16(5), e0251601.  doi: 10.1371/journal.pone.0251601

Date

BioLife Solutions logo

This website uses cookies to ensure you get the best experience on our website.

Accept & close